These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
401 related articles for article (PubMed ID: 19207861)
61. The role of the histocompatibility laboratory in desensitization for transplantation. Leffell MS; Zachary AA Curr Opin Organ Transplant; 2009 Aug; 14(4):398-402. PubMed ID: 19417655 [TBL] [Abstract][Full Text] [Related]
62. The complement-mediated prozone effect in the Luminex single-antigen bead assay and its impact on HLA antibody determination in patient sera. Weinstock C; Schnaidt M Int J Immunogenet; 2013 Jun; 40(3):171-7. PubMed ID: 22913810 [TBL] [Abstract][Full Text] [Related]
63. Tools for human leukocyte antigen antibody detection and their application to transplanting sensitized patients. Fuggle SV; Martin S Transplantation; 2008 Aug; 86(3):384-90. PubMed ID: 18698240 [TBL] [Abstract][Full Text] [Related]
64. Unexpected anti-HLA-DR and -DQ alloantibodies after nephrectomy of an HLA-DR and -DQ identical first renal transplant. Proust B; Kennel A; Ladrière M; Kessler M; Perrier P Transpl Immunol; 2009 Jul; 21(3):166-8. PubMed ID: 19341797 [TBL] [Abstract][Full Text] [Related]
65. Pretransplantation monitoring of HLA antibodies by complement dependent cytotoxicity and Luminex-based assays. Katalinić N; Fućak M; Crnić T; Ćurković M; Starčević A; Balen S Wien Klin Wochenschr; 2017 Jan; 129(1-2):33-37. PubMed ID: 27743177 [TBL] [Abstract][Full Text] [Related]
66. Anti-HLA Antibodies Testing on Solid Phase: Comparative Evaluation of Different Kit Vendors Through Luminex Technology. Minucci PB; Resse M; Sabia C; Esposito A; De Iorio G; Napoli C Exp Clin Transplant; 2017 Dec; 15(6):636-640. PubMed ID: 28585912 [TBL] [Abstract][Full Text] [Related]
69. Detection of immunoglobulin G human leukocyte antigen-specific alloantibodies in renal transplant patients using single-antigen-beads is compromised by the presence of immunoglobulin M human leukocyte antigen-specific alloantibodies. Kosmoliaptsis V; Bradley JA; Peacock S; Chaudhry AN; Taylor CJ Transplantation; 2009 Mar; 87(6):813-20. PubMed ID: 19300182 [TBL] [Abstract][Full Text] [Related]
70. Predictive value of the Luminex single antigen panel for detecting flow cytometry cross-match positivity. Moreno C; Burgos L; Pérez-Robles C; Delgado JA; Mata JJ; Errasti P; Martín P; Merino J; Sánchez-Ibarrola A Hum Immunol; 2012 May; 73(5):517-21. PubMed ID: 22425736 [TBL] [Abstract][Full Text] [Related]
71. Luminex and antibody detection in kidney transplantation. Picascia A; Infante T; Napoli C Clin Exp Nephrol; 2012 Jun; 16(3):373-81. PubMed ID: 22552384 [TBL] [Abstract][Full Text] [Related]
72. Hyperacute rejection after lung transplantation caused by undetected low-titer anti-HLA antibodies. Masson E; Stern M; Chabod J; Thévenin C; Gonin F; Rebibou JM; Tiberghien P J Heart Lung Transplant; 2007 Jun; 26(6):642-5. PubMed ID: 17543791 [TBL] [Abstract][Full Text] [Related]
73. Challenging the golden standard in defining donor-specific antibodies: does the solid phase assay meet the expectations? Zoet YM; Brand-Schaaf SH; Roelen DL; Mulder A; Claas FH; Doxiadis II Tissue Antigens; 2011 Mar; 77(3):225-8. PubMed ID: 21299527 [TBL] [Abstract][Full Text] [Related]
74. Humoral responses directed against non-human leukocyte antigens in solid-organ transplantation. Dragun D Transplantation; 2008 Oct; 86(8):1019-25. PubMed ID: 18946337 [TBL] [Abstract][Full Text] [Related]
75. Antiallograft antibodies: relevance, detection, and monitoring. Leffell MS; Zachary AA Curr Opin Organ Transplant; 2010 Feb; 15(1):2-7. PubMed ID: 19898236 [TBL] [Abstract][Full Text] [Related]
76. A reevaluation of the role of IgM Non-HLA antibodies in cardiac transplantation. Smith JD; Hamour IM; Burke MM; Mahesh B; Stanford RE; Haj-Yahia S; Robinson DR; Kaul P; Yacoub MH; Banner NR; Rose ML Transplantation; 2009 Mar; 87(6):864-71. PubMed ID: 19300190 [TBL] [Abstract][Full Text] [Related]
77. Improved flow cytometry based cytotoxicity and binding assay for clinical antibody HLA crossmatching. Alheim M; Paul PK; Hauzenberger DM; Wikström AC Hum Immunol; 2015 Nov; 76(11):849-57. PubMed ID: 26429307 [TBL] [Abstract][Full Text] [Related]
78. Isoniazid in patient plasma may cause a false-positive result on the complement-dependent cytotoxicity test. Poli F; Innocente A; Cagni N; Brambilla C; Crespiatico L; Colombo MB; Scalamogna M Hum Immunol; 2009 Sep; 70(9):758-9. PubMed ID: 19539003 [TBL] [Abstract][Full Text] [Related]
79. Prediction of crossmatch outcome of highly sensitized patients by single and/or multiple antigen bead luminex assay. Vaidya S; Partlow D; Susskind B; Noor M; Barnes T; Gugliuzza K Transplantation; 2006 Dec; 82(11):1524-8. PubMed ID: 17164726 [TBL] [Abstract][Full Text] [Related]
80. Organ procurement and transplantation network/united network for organ sharing histocompatibility committee collaborative study to evaluate prediction of crossmatch results in highly sensitized patients. Nikaein A; Cherikh W; Nelson K; Baker T; Leffell S; Bow L; Crowe D; Connick K; Head MA; Kamoun M; Kimball P; Klohe E; Noreen H; Rebellato L; Sell T; Sullivan K; Land G Transplantation; 2009 Feb; 87(4):557-62. PubMed ID: 19307794 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]